High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer

John Joseph Wallbillich, S Josyula, U Saini, RA Zingarelli, KDP Dorayappan, MK Riley, Wanner RA, K Selvendiran

Research output: Contribution to journalArticle

9 Scopus citations
Original languageEnglish (US)
Article number28114390
JournalPLoS One
StatePublished - Jan 2017

Cite this

Wallbillich, J. J., Josyula, S., Saini, U., Zingarelli, RA., Dorayappan, KDP., Riley, MK., RA, W., & Selvendiran, K. (2017). High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer. PLoS One, [28114390].